CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 191 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $180,222 | +20.9% | 6,614,871 | -1.3% | 0.31% | +42.8% |
Q2 2023 | $149,074 | +1.4% | 6,699,971 | -1.3% | 0.22% | +10.3% |
Q1 2023 | $147,030 | -0.7% | 6,788,069 | -6.9% | 0.20% | -3.9% |
Q4 2022 | $148,037 | -99.9% | 7,288,871 | +1.3% | 0.20% | -22.2% |
Q3 2022 | $184,543,000 | -0.9% | 7,197,471 | -8.1% | 0.26% | +18.1% |
Q2 2022 | $186,289,000 | +6.5% | 7,833,871 | +0.8% | 0.22% | +7.8% |
Q1 2022 | $174,992,000 | +10.1% | 7,770,516 | -3.2% | 0.20% | +3.5% |
Q4 2021 | $158,868,000 | -2.1% | 8,023,616 | -2.7% | 0.20% | -5.7% |
Q3 2021 | $162,318,000 | -13.4% | 8,247,841 | -3.2% | 0.21% | -10.3% |
Q2 2021 | $187,488,000 | -10.2% | 8,522,196 | -2.9% | 0.23% | -10.0% |
Q1 2021 | $208,729,000 | -14.6% | 8,773,796 | -6.1% | 0.26% | -1.9% |
Q4 2020 | $244,374,000 | +46.2% | 9,341,496 | -2.8% | 0.26% | +58.7% |
Q3 2020 | $167,192,000 | +11.4% | 9,605,996 | +7.7% | 0.17% | +28.5% |
Q2 2020 | $150,034,000 | +52.0% | 8,919,996 | +7.4% | 0.13% | +35.4% |
Q1 2020 | $98,721,000 | +5.0% | 8,302,841 | +6.9% | 0.10% | +33.3% |
Q4 2019 | $93,995,000 | +1.9% | 7,768,214 | +19.1% | 0.07% | -7.7% |
Q3 2019 | $92,220,000 | +47.9% | 6,524,209 | +16.7% | 0.08% | +41.8% |
Q2 2019 | $62,334,000 | +5.0% | 5,590,509 | +10.5% | 0.06% | +1.9% |
Q1 2019 | $59,379,000 | -4.4% | 5,057,809 | +8.8% | 0.05% | -20.6% |
Q4 2018 | $62,087,000 | +0.3% | 4,647,209 | +5.2% | 0.07% | +6.2% |
Q3 2018 | $61,907,000 | -58.0% | 4,415,600 | -51.7% | 0.06% | -20.0% |
Q2 2018 | $147,245,000 | +86.5% | 9,143,900 | +90.6% | 0.08% | -7.0% |
Q1 2018 | $78,935,000 | -11.8% | 4,798,500 | -3.1% | 0.09% | -13.1% |
Q4 2017 | $89,478,000 | +26.3% | 4,954,500 | +35.0% | 0.10% | +19.3% |
Q3 2017 | $70,826,000 | +123.7% | 3,669,755 | +36.8% | 0.08% | +107.5% |
Q2 2017 | $31,664,000 | +55.5% | 2,683,400 | +44.4% | 0.04% | +42.9% |
Q1 2017 | $20,369,000 | +86.1% | 1,858,500 | +23.3% | 0.03% | +64.7% |
Q4 2016 | $10,944,000 | +200.7% | 1,507,500 | +169.2% | 0.02% | +183.3% |
Q3 2016 | $3,640,000 | +114.6% | 560,000 | +80.3% | 0.01% | +100.0% |
Q2 2016 | $1,696,000 | +89.3% | 310,600 | +62.3% | 0.00% | +50.0% |
Q1 2016 | $896,000 | -60.9% | 191,400 | -58.4% | 0.00% | -60.0% |
Q4 2015 | $2,293,000 | +34.9% | 460,400 | +1.8% | 0.01% | +25.0% |
Q3 2015 | $1,700,000 | -43.6% | 452,200 | -9.9% | 0.00% | -42.9% |
Q2 2015 | $3,015,000 | +872.6% | 501,614 | +805.4% | 0.01% | +600.0% |
Q1 2015 | $310,000 | – | 55,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
S&T BANK/PA | 350,924 | $7,601 | 1.37% |
Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |